TippingPoint Biosciences-preview

Tippingpointbiosciences

TippingPoint Biosciences

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.tippingpointbiosciences.com/

Last Round

Seed

Mar 31, 2026

Total Funding Raised

$7M

Momentum Score

25 /100

Company Overview

TippingPoint Biosciences is a biotechnology company that operates a drug discovery platform intended to identify treatments for diseases caused by defects in DNA packaging.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

drug discovery platformchromatin targetingDIPGDiffuse Intrinsic Pontine Gliomacell-free screeningplatform biotechpediatric oncologyepigenetic therapiesundruggable targetsprotein-protein interfacesfirst-in-class drugstechbiorare disease therapeuticsbiotech platform licensingneurodegenerative diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TippingPoint Biosciences Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TippingPoint Biosciences Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Mar 31, 2026
Pre Seed	Sep 4, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Laura Hsieh

CEO Founder

Founding Team

TippingPoint Biosciences Investors

Notable investors and investment history

Investor	Rounds
Yuvaan Tiwari Foundation	Pre Seed
Freeflow Ventures	Seed
WECAN Capital Partners	Seed
The Sontag Foundation	Pre Seed
BrightEdge	Pre Seed, Seed
Freeflow Ventures	Seed
Mission BioCapital	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 6, 2026
Monthly visitors increased 51% MoM.
Mar 31, 2026
$5M seed round completed.

View all signals

TippingPoint Biosciences Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

TippingPoint Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TippingPoint Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range7

Year Founded2022

Last FundingMar 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.